Hyundai Bioscience Co., Ltd. 048410.KQ Stock
Hyundai Bioscience Co., Ltd. Price Chart
Hyundai Bioscience Co., Ltd. 048410.KQ Financial and Trading Overview
| Hyundai Bioscience Co., Ltd. stock price | 19530 KRW |
| Previous Close | 31750 KRW |
| Open | 31800 KRW |
| Bid | 32550 KRW x 0 |
| Ask | 32600 KRW x 0 |
| Day's Range | 31750 - 35800 KRW |
| 52 Week Range | 18450 - 41600 KRW |
| Volume | 2.39M KRW |
| Avg. Volume | 836.81K KRW |
| Market Cap | 1.13T KRW |
| Beta (5Y Monthly) | 1.78638 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
048410.KQ Valuation Measures
| Enterprise Value | 1.03T KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 130.47005 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 118.477 |
| Enterprise Value/EBITDA | -58.018 |
Trading Information
Hyundai Bioscience Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 1.78638 |
| 52-Week Change | 33.12% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 41600 KRW |
| 52 Week Low | 18450 KRW |
| 50-Day Moving Average | 22975.6 KRW |
| 200-Day Moving Average | 24889.15 KRW |
048410.KQ Share Statistics
| Avg. Volume (3 month) | 836.81K KRW |
| Avg. Daily Volume (10-Days) | 2.1M KRW |
| Shares Outstanding | 34.18M |
| Float | 34.55M |
| Short Ratio | N/A |
| % Held by Insiders | 12.82% |
| % Held by Institutions | 6.93% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 0.1:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | -209.89% |
| Operating Margin (ttm) | -225.89% |
| Gross Margin | 28.60% |
| EBITDA Margin | -204.20% |
Management Effectiveness
| Return on Assets (ttm) | -14.22% |
| Return on Equity (ttm) | -26.51% |
Income Statement
| Revenue (ttm) | 8.66B KRW |
| Revenue Per Share (ttm) | 221.49 KRW |
| Quarterly Revenue Growth (yoy) | -3.30% |
| Gross Profit (ttm) | 3.39B KRW |
| EBITDA | -17681985536 KRW |
| Net Income Avi to Common (ttm) | -18174484480 KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 24.77B KRW |
| Total Cash Per Share (mrq) | 624.22 KRW |
| Total Debt (mrq) | 7.05B KRW |
| Total Debt/Equity (mrq) | 10.23 KRW |
| Current Ratio (mrq) | 3.637 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -17199579136 KRW |
| Levered Free Cash Flow (ttm) | -10323505152 KRW |
Profile of Hyundai Bioscience Co., Ltd.
| Country | South Korea |
| State | N/A |
| City | Seoul |
| Address | Academic Cooperation Building |
| ZIP | N/A |
| Phone | 82 70 7008 0114 |
| Website | https://www.hyundaibioscience.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Hyundai Bioscience Co., Ltd., a biotechnology company, develops and commercializes bio-fusion technology for delivering active ingredients to human body. The company provides Vitabrid C12, a new-conceptual vitamin C product that delivers active vitamin C into the skin. It also develops organic-inorganic hybrid technology, a drug delivery system technology that allows the selective and effective delivery of active substances on the target area in combination with bio-friendly minerals, as well as in anticancer drug carrier technology. The company was founded in 2000 and is based in Seoul, South Korea.
Q&A For Hyundai Bioscience Co., Ltd. Stock
What is a current 048410.KQ stock price?
Hyundai Bioscience Co., Ltd. 048410.KQ stock price today per share is 19530 KRW.
How to purchase Hyundai Bioscience Co., Ltd. stock?
You can buy 048410.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hyundai Bioscience Co., Ltd.?
The stock symbol or ticker of Hyundai Bioscience Co., Ltd. is 048410.KQ.
How many shares does Hyundai Bioscience Co., Ltd. have in circulation?
The max supply of Hyundai Bioscience Co., Ltd. shares is 39.81M.
What is Hyundai Bioscience Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Hyundai Bioscience Co., Ltd. PE Ratio is now.
What was Hyundai Bioscience Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Hyundai Bioscience Co., Ltd. EPS is 0 KRW over the trailing 12 months.